
Myriad Genetics MYGN
$ 7.22
0.14%
Quarterly report 2025-Q3
added 11-04-2025
Myriad Genetics DIO Ratio 2011-2025 | MYGN
Annual DIO Ratio Myriad Genetics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35.8 | 32.5 | 32 | - | - | - | 70.7 | 90 | 88.9 | 62.2 | 79.9 | 23 | 65.3 | 44.3 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 90 | 23 | 56.8 |
Quarterly DIO Ratio Myriad Genetics
| 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 44.5 | 41.8 | - | 37.6 | 35.9 | 32.9 | - | 37.7 | 35 | 32.3 | - | 17.7 | 14.3 | 29.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 89.9 | 93.3 | 102 | 52.1 | 113 | 128 | 123 | 93.5 | 89.7 | 84.8 | 87.7 | 67.2 | 66.8 | 58.4 | 67.7 | 62.2 | 33.3 | 10 | 21.3 | 24.4 | 37.5 | 61.8 | 72.6 | 67.8 | 71.6 | 71.2 | 72.4 | 58.5 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 128 | 10 | 60 |
DIO Ratio of other stocks in the Diagnostics research industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
243 | $ 16.38 | 3.97 % | $ 170 M | ||
|
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
245 | $ 1.6 | -1.23 % | $ 2.03 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M | ||
|
Castle Biosciences
CSTL
|
48.7 | $ 39.39 | 1.97 % | $ 1.09 B | ||
|
Chembio Diagnostics
CEMI
|
97.6 | - | 0.22 % | $ 16.8 M | ||
|
Danaher Corporation
DHR
|
92.9 | $ 228.73 | 0.98 % | $ 167 B | ||
|
DarioHealth Corp.
DRIO
|
165 | $ 11.97 | 0.67 % | $ 340 M | ||
|
DexCom
DXCM
|
119 | $ 67.19 | 0.34 % | $ 25.9 B | ||
|
Exact Sciences Corporation
EXAS
|
240 | $ 101.46 | -0.04 % | $ 18.8 B | ||
|
Fulgent Genetics
FLGT
|
7.17 | $ 27.23 | 0.31 % | $ 823 M | ||
|
Global Cord Blood Corporation
CO
|
89.7 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
42.1 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
48.3 | $ 20.72 | 0.78 % | $ 1.11 B | ||
|
Enzo Biochem
ENZ
|
156 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
304 | $ 0.33 | -3.34 % | $ 9.68 M | ||
|
Quidel Corporation
QDEL
|
133 | $ 28.72 | -0.28 % | $ 1.21 B | ||
|
Guardant Health
GH
|
78.4 | $ 103.82 | 1.72 % | $ 12.7 B | ||
|
Aspira Women's Health
AWH
|
23.1 | - | -6.19 % | $ 10.5 M | ||
|
Heska Corporation
HSKA
|
137 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
137 | $ 135.16 | 0.22 % | $ 21.5 B | ||
|
Charles River Laboratories International
CRL
|
35.3 | $ 197.73 | 2.46 % | $ 10.2 B | ||
|
Quotient Limited
QTNT
|
386 | - | -11.32 % | $ 1.1 M | ||
|
Quest Diagnostics Incorporated
DGX
|
10.4 | $ 184.0 | 0.82 % | $ 20.4 B | ||
|
Laboratory Corporation of America Holdings
LH
|
18.8 | $ 264.75 | 0.22 % | $ 22.2 B | ||
|
ICON Public Limited Company
ICLR
|
0.213 | $ 187.27 | 0.37 % | $ 15.4 B | ||
|
IDEXX Laboratories
IDXX
|
91.6 | $ 707.12 | 0.41 % | $ 58.3 B | ||
|
Lantheus Holdings
LNTH
|
44.2 | $ 66.85 | 0.35 % | $ 4.63 B | ||
|
Agilent Technologies
A
|
97.1 | $ 140.96 | 0.93 % | $ 42.9 B | ||
|
Mettler-Toledo International
MTD
|
79 | $ 1 405.6 | 0.84 % | $ 29.8 B | ||
|
Biomerica
BMRA
|
147 | $ 2.53 | -1.94 % | $ 5.81 M | ||
|
Bioventus
BVS
|
175 | $ 7.64 | 1.13 % | $ 479 M | ||
|
NeoGenomics
NEO
|
25.1 | $ 11.87 | 0.16 % | $ 1.5 B | ||
|
Neogen Corporation
NEOG
|
147 | $ 6.82 | -0.66 % | $ 1.48 B | ||
|
Motus GI Holdings
MOTS
|
3.37 K | - | -34.28 % | $ 263 K |